Agenda Archive

END OF DAY 1, NETWORKING DRINKS & PRIZE DRAW

Why phase‑appropriate logistics matters: Contrast early‑phase needs (speed, flexibility, limited batches) with later‑phase demands (cost efficiency, scale, partnerships).
Defining scope + managing complexity: Clarify what logistics covers (R&D, CMC, clinical, cold chain, inventory, vendor management) and avoid “boiling the ocean” by right‑sizing processes.
Building reliable systems: Align on cold‑chain qualification/validation, understand regulatory implications, and evolve tools from spreadsheets to integrated supply chain software.
People & partners as drivers of success: Leverage SME expertise, combine AI with human intelligence, and manage vendors intentionally to support each clinical phase transition

Valuation of clinical items moving through borders
HS/HTS codes for blinded clinical shipments versus clinical supplies moving to distribution sites
VAT expenses: how they apply, when and how they can be recovered
Sanctions and exemptions in the pharmaceutical industry
Overall best practices to approach your clinical studies from a customs perspective

Establishing cross functional teams early to strengthen supply chain performance
Implementing agreements and team charters to support effective collaboration
Improving clinical supply chain management and trial timelines through alignment

Recognizing where comparator sourcing typically goes wrong and how those issues affect enrollment, supply, timelines, and cost
Addressing key challenges such as shelf life, long lead times, country-specific requirements, and blinding needs
Sharing practical mitigation strategies and lessons learned from real planning scenarios